- Home
- QSI vs CADL Comparison
QSI vs CADL Comparison
Compare QSI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- CADL
- Stock Information
- Founded
- QSI 2013
- CADL 1999
- Country
- QSI United States
- CADL United States
- Employees
- QSI N/A
- CADL N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- QSI Health Care
- CADL Health Care
- Exchange
- QSI Nasdaq
- CADL Nasdaq
- Market Cap
- QSI 214.3M
- CADL 234.8M
- IPO Year
- QSI N/A
- CADL 2021
- Fundamental
- Price
- QSI $1.26
- CADL $4.81
- Analyst Decision
- QSI Strong Buy
- CADL Strong Buy
- Analyst Count
- QSI 3
- CADL 4
- Target Price
- QSI $3.42
- CADL $21.00
- AVG Volume (30 Days)
- QSI 2.7M
- CADL 843.6K
- Earning Date
- QSI 05-15-2025
- CADL 05-20-2025
- Dividend Yield
- QSI N/A
- CADL N/A
- EPS Growth
- QSI N/A
- CADL N/A
- EPS
- QSI N/A
- CADL N/A
- Revenue
- QSI $3,058,000.00
- CADL N/A
- Revenue This Year
- QSI $151.18
- CADL N/A
- Revenue Next Year
- QSI $172.07
- CADL N/A
- P/E Ratio
- QSI N/A
- CADL N/A
- Revenue Growth
- QSI 182.63
- CADL N/A
- 52 Week Low
- QSI $0.61
- CADL $3.79
- 52 Week High
- QSI $5.77
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- QSI 51.74
- CADL 42.39
- Support Level
- QSI $1.15
- CADL $4.34
- Resistance Level
- QSI $1.35
- CADL $5.34
- Average True Range (ATR)
- QSI 0.07
- CADL 0.33
- MACD
- QSI 0.02
- CADL 0.10
- Stochastic Oscillator
- QSI 64.71
- CADL 47.11
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.